Every investor in Medtronic plc ( NYSE:MDT) should be aware of the most powerful shareholder groups. The group holding the ...

Discover why Medtronic is a top Dividend Aristocrat with strong financial performance and potential for 12% annual returns ...

Axonics AXNX recently announced that a jury in the U.S. District Court for the Central District of California ruled ...

Analyst Josh Jennings from TD Cowen maintained a Buy rating on Medtronic (MDT – Research Report) and keeping the price target at $95.00.

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's ...

A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run ...

Medtronic acquired the VitalFlow extracorporeal membrane oxygenation technology by purchasing MC3 Cardiopulmonary.

Two of the top 10 largest medtech companies will partner together on robotic head and spine procedures, with Medtronic ...

Medtronic (NYSE: MDT) announced today that Fortune named it to its 2024 "Change the World" list for its Symplicity blood ...

Medtronic, a global developer and manufacturer of medical devices for chronic diseases, is now a $111 billion (by market cap) ...

The partnership will enable to incorporate Siemens Healthineers' Multitom Rax imaging into Medtronic's AiBLE ecosystem.